EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smolle-Juettner, F. M.
Right arrow Articles by Friehs, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smolle-Juettner, F. M.
Right arrow Articles by Friehs, G.

European Journal of Cardio-Thoracic Surgery, Vol 10, 947-950, Copyright © 1996 by European Association for Cardio-thoracic Surgery


ARTICLES

"Adjuvant" external radiation of the mediastinum in radically resected non-small cell lung cancer

FM Smolle-Juettner, R Mayer, H Pinter, G Stuecklschweiger, KS Kapp, S Gabor, B Ratzenhofer, A Hackl and G Friehs
Department of Thoracic and Hyperbaric Surgery, University of Graz, Austria.

OBJECTIVE: The effect of postoperative external beam radiation in MO non-small cell lung cancer resected with curative intention was evaluated in a randomized trial. METHODS: In 155 patients (121 males, 34 females; mean age: 59 years) 105 lobectomies, 12 bilobectomies and 38 pneumonectomies with radical lymph node dissection to the contralateral side were carried out. Histology revealed squamous cell (n = 68), adeno- (n = 53), large cell (n = 21), adenosquamous (n = 6) or bronchioloalveolar type (n = 7) carcinomas. The pathologic stages T1 (n = 38), T2 (n = 89), T3 (n = 28); NO (n = 39), N1 (n = 67), and N2 (n = 49) were evenly distributed between the two treatment groups: group A (72 patients) had no further oncologic treatment, while group B (83 patients) had external beam radiation to the mediastinum (50-56 Gy, 8 or 23 MeV photons, 2 Gy/day, 5 days a week) beginning 4 weeks after the operation. RESULTS: The overall 5-year survival rate of the whole collective was 24.1% without any significant difference between the radiotherapy group B (29.7%) and the control group A (20.4%) (log-rank test: P > 0.05). The overall 5-year recurrence-free survival rate was 20.1%, with no difference between groups B and A (radiotherapy: 22.7, controls: 15.6%, long-rank test: P > 0.05). There was no difference in the incidence of distant metastases (external beam radiation: n = 32; controls: n = 38). The rate of local recurrences at the bronchial stump or in the mediastinum, however, was significantly reduced in the radiotherapy group (n = 5) compared with 17 in the controls (P < 0.01 chi-square test). A multivariate analysis confirmed the independent influence of postoperative radiotherapy on the incidence of local recurrence. CONCLUSIONS: External radiation of the mediastinum in radically resected non-small cell lung cancer reduces the risk of local recurrence, but has no influence on distant metastastic spread and overall survival.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Barlesi, C. Doddoli, C. Gimenez, B. Chetaille, R. Giudicelli, P. Fuentes, J.-P. Kleisbauer, and P. Thomas
Bronchioloalveolar carcinoma: myths and realities in the surgical management
Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
S. Cykert and N. Phifer
Surgical Decisions for Early Stage, Non-Small Cell Lung Cancer: Which Racially Sensitive Perceptions of Cancer Are Likely to Explain Racial Variation in Surgery?
Med Decis Making, March 1, 2003; 23(2): 167 - 176.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H.S. Hofmann, C. Taege, C. Lautenschlager, H. Neef, and R.E. Silber
Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer
Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 606 - 610.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Arriagada and J.-P. Pignon
Is Meta-analysis a Metaphysical or a Scientific Method?
Chest, September 1, 2000; 118(3): 832 - 834.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.